Skip to content

Efficacy of hydrochlorothiazide at renal pelvis stone free time after extra corporeal shock wake lithotripsy (ESWL)

Efficacy of hydrochlorothiazide at stone free time after extra corporeal shock wake lithotripsy on patients referred to ESWL ward of Moradi hospital of Rafsanjan

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20171104037212N2
Enrollment
278
Registered
2018-01-24
Start date
2017-11-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stone in kidney. Calculus of kidney

Interventions

Intervention 1: Intervention group: Hydrochlorothiazide Tablet administration 25 mg, every 12 hours for two weeks. Intervention 2: Control group: Tablet Vitamin B1 administration 150mg, every 12 hours
Treatment - Drugs
Placebo
Intervention group: Hydrochlorothiazide Tablet administration 25 mg, every 12 hours for two weeks
Control group: Tablet Vitamin B1 administration 150mg, every 12 hours for two weeks

Sponsors

Rafsanjan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with Renal pelvic stone Stone size equal or below 20 millimeters

Exclusion criteria

Exclusion criteria: Renal failure History of ?Extar corporeal shock wave lithotripsy History of renal surgery History of stone passage History of using Diuretic drugs History of using smooth muscle relaxant drugs Patients with moderate or severe hydronephrosis

Design outcomes

Primary

MeasureTime frame
The duration, the number of days from the time of the Extracorporeal shock wave lithotripsy to the time of last stone fragment passage. Timepoint: Day after Extracorporeal shock wave lithotripsy. Method of measurement: Check list.

Secondary

MeasureTime frame
Stone free. Timepoint: daily. Method of measurement: Check list.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammadreza Mokhtaree

Rafsanjan University of medical sciences

mrmokhtaree@rums.ac.ir+98 34 3426 0080

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026